In this respiratory diseases roundup, researchers examine COVID-19 protection, hospitalization rates, long COVID predictors, and rare disease mortality risks.
A recent feasibility study evaluated the acceptability and impact of smartphone notifications on medication adherence in patients with gout prescribed allopurinol.
In a phase 3 trial, inebilizumab, a monoclonal antibody targeting CD19+ B cells, reduced flare rates and improved treatment-free and glucocorticoid-free remission in patients with immunoglobulin G4-related...
A multicenter, randomized controlled trial revealed that continuing immunosuppressants, with or without low-dose glucocorticoids, reduces relapse rates for patients with stable IgG4-related disease compared...
In a study that assessed pericoronary adipose tissue (PCAT) density, researchers noted an association between higher PCAT density and greater coronary plaque burden and cardiovascular disease in people with...
In a cohort study, researchers observed a significant decrease in incident reinfection among patients with Hepatitis C who received increased follow-up after achieving sustained virologic response.
Researchers who are a part of the American Gastroenterological Association (AGA) developed a list of guidelines for the use of fecal microbiota-based therapies in patients with Clostridioides difficile...
A systematic review and meta-analysis examined the clinical differences between adult patients with neuromyelitis optica spectrum disorders and those with multiple sclerosis.
Researchers examined the efficacy and safety of a humanized monoclonal antibody for the treatment of active psoriatic arthritis in some patient populations.
